Last update 04 Nov 2024
Beijing Suncadia Pharmaceuticals Co., Ltd
Subsidiary Company|
2019|
Beijing Shi, China
Last update 04 Nov 2024
Overview
Basic Info
Introduction Founded in 2019 in the Yizhuang district, Beijing Suncadia Pharmaceuticals Co., Ltd is an affiliate of the Jiangsu Hengrui Medicine Co., Ltd. The parent company, which was established in 1970, specializes in the innovation, development, production, and marketing of high-quality pharmaceutical products. It made its debut on the Shanghai Stock Exchange in the year 2000. |
Tags
Cardiovascular Diseases
Nervous System Diseases
Endocrinology and Metabolic Disease
Antibody
Small molecule drug
Monoclonal antibody
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
单次和多次口服HRS-5346片在健康受试者的安全性、耐受性与药代动力学、药效学及食物影响的 I 期临床研究
[Translation] Phase I clinical study on the safety, tolerability, pharmacokinetics, pharmacodynamics and food effects of single and multiple oral doses of HRS-5346 tablets in healthy subjects
Evaluation of the Efficacy and Safety of Multiple Subcutaneous Injections of SHR-1918 in Patients With Hyperlipidemia in Poor Control: a Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trials
A Phase Ib Clinical Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2004 Injection in Patients With Atrial Fibrillation
100 Clinical Results associated with Beijing Suncadia Pharmaceuticals Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Beijing Suncadia Pharmaceuticals Co., Ltd
Login to view more data
100 Translational Medicine associated with Beijing Suncadia Pharmaceuticals Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Dec 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
1
1
IND Approval
Phase 1
1
3
Phase 2
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free